Autolus Therapeutics Plc (AUTL)
1.81
+0.04
(+2.26%)
USD |
NASDAQ |
Oct 09, 16:00
1.81
0.00 (0.00%)
After-Hours: 20:00
Autolus Therapeutics Free Cash Flow : -240.12M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -240.12M |
| March 31, 2026 | -295.51M |
| December 31, 2025 | -311.43M |
| September 30, 2025 | -306.93M |
| June 30, 2025 | -313.39M |
| March 31, 2025 | -283.85M |
| December 31, 2024 | -241.09M |
| September 30, 2024 | -205.61M |
| June 30, 2024 | -160.70M |
| March 31, 2024 | -151.46M |
| December 31, 2023 | -156.87M |
| September 30, 2023 | -145.68M |
| June 30, 2023 | -142.96M |
| March 31, 2023 | -133.73M |
| Date | Value |
|---|---|
| December 31, 2022 | -123.07M |
| September 30, 2022 | -118.69M |
| June 30, 2022 | -118.60M |
| March 31, 2022 | -123.28M |
| December 31, 2021 | -126.72M |
| September 30, 2021 | -149.18M |
| June 30, 2021 | -153.68M |
| March 31, 2021 | -145.01M |
| December 31, 2020 | -132.44M |
| September 30, 2020 | -134.42M |
| June 30, 2020 | -119.58M |
| March 31, 2020 | -112.98M |
| December 31, 2019 | -120.15M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Bicycle Therapeutics Plc | -207.47M |
| Biodexa Pharmaceuticals Plc | -10.63M |
| argenx SE | 1.090B |
| Mereo BioPharma Group Plc | -25.58M |
| Evaxion AS | -- |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -25.16M |
| Cash from Investing (Quarterly) | 68.03M |
| Cash from Financing (Quarterly) | -2.144M |
| Free Cash Flow Per Share (Quarterly) | -0.098 |
| Free Cash Flow to Equity (Quarterly) | -24.77M |
| Free Cash Flow to Firm (Quarterly) | -26.08M |
| Free Cash Flow Yield | -49.85% |